

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | carnitine shuttle (GO:0006853) | 5.30014459 |
| 2 | fatty acid transmembrane transport (GO:1902001) | 5.11930554 |
| 3 | sarcomere organization (GO:0045214) | 4.71769526 |
| 4 | regulation of sequestering of triglyceride (GO:0010889) | 4.59422778 |
| 5 | cardiac myofibril assembly (GO:0055003) | 4.57502592 |
| 6 | tricarboxylic acid cycle (GO:0006099) | 4.52429265 |
| 7 | amino-acid betaine transport (GO:0015838) | 4.52231986 |
| 8 | carnitine transport (GO:0015879) | 4.52231986 |
| 9 | carnitine transmembrane transport (GO:1902603) | 4.43989636 |
| 10 | lysine catabolic process (GO:0006554) | 4.31359497 |
| 11 | lysine metabolic process (GO:0006553) | 4.31359497 |
| 12 | fatty acid beta-oxidation (GO:0006635) | 4.31309536 |
| 13 | plasma membrane repair (GO:0001778) | 4.13184962 |
| 14 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.12223052 |
| 15 | 2-oxoglutarate metabolic process (GO:0006103) | 4.11109745 |
| 16 | valine metabolic process (GO:0006573) | 4.10429913 |
| 17 | myofibril assembly (GO:0030239) | 4.02285617 |
| 18 | quaternary ammonium group transport (GO:0015697) | 3.96943663 |
| 19 | cellular response to epinephrine stimulus (GO:0071872) | 3.86496634 |
| 20 | biotin metabolic process (GO:0006768) | 3.84117372 |
| 21 | tricarboxylic acid metabolic process (GO:0072350) | 3.79520143 |
| 22 | regulation of fatty acid oxidation (GO:0046320) | 3.77642760 |
| 23 | low-density lipoprotein particle clearance (GO:0034383) | 3.71728192 |
| 24 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.70826779 |
| 25 | fatty acid oxidation (GO:0019395) | 3.70235638 |
| 26 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.68831682 |
| 27 | NADH metabolic process (GO:0006734) | 3.65086654 |
| 28 | actin-myosin filament sliding (GO:0033275) | 3.63531646 |
| 29 | muscle filament sliding (GO:0030049) | 3.63531646 |
| 30 | lipid oxidation (GO:0034440) | 3.62579941 |
| 31 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.59749944 |
| 32 | fatty acid catabolic process (GO:0009062) | 3.58950863 |
| 33 | extracellular matrix assembly (GO:0085029) | 3.58748478 |
| 34 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.57684004 |
| 35 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.55109515 |
| 36 | positive regulation of fatty acid oxidation (GO:0046321) | 3.54615393 |
| 37 | acetyl-CoA metabolic process (GO:0006084) | 3.42874811 |
| 38 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.39970517 |
| 39 | branched-chain amino acid metabolic process (GO:0009081) | 3.35579898 |
| 40 | regulation of skeletal muscle contraction (GO:0014819) | 3.34943373 |
| 41 | cardiac muscle contraction (GO:0060048) | 3.34800875 |
| 42 | response to epinephrine (GO:0071871) | 3.33511079 |
| 43 | aspartate family amino acid catabolic process (GO:0009068) | 3.29728814 |
| 44 | cardiac muscle cell development (GO:0055013) | 3.29604106 |
| 45 | intracellular lipid transport (GO:0032365) | 3.22252477 |
| 46 | actomyosin structure organization (GO:0031032) | 3.20701295 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.19836806 |
| 48 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.19393444 |
| 49 | oxaloacetate metabolic process (GO:0006107) | 3.18625735 |
| 50 | branched-chain amino acid catabolic process (GO:0009083) | 3.18542300 |
| 51 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.17644157 |
| 52 | cell migration involved in heart development (GO:0060973) | 3.16696519 |
| 53 | extracellular fibril organization (GO:0043206) | 3.14623091 |
| 54 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.13903759 |
| 55 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.13473040 |
| 56 | cardiac cell development (GO:0055006) | 3.12472559 |
| 57 | surfactant homeostasis (GO:0043129) | 3.12403226 |
| 58 | heart trabecula formation (GO:0060347) | 3.10769564 |
| 59 | actin-mediated cell contraction (GO:0070252) | 3.09581721 |
| 60 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.06273982 |
| 61 | protein heterotrimerization (GO:0070208) | 3.05860553 |
| 62 | regulation of actin filament-based movement (GO:1903115) | 3.05609234 |
| 63 | short-chain fatty acid metabolic process (GO:0046459) | 3.04203591 |
| 64 | carnitine metabolic process (GO:0009437) | 3.02748226 |
| 65 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.99867783 |
| 66 | monocarboxylic acid catabolic process (GO:0072329) | 2.96877331 |
| 67 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.96252879 |
| 68 | brown fat cell differentiation (GO:0050873) | 2.95183926 |
| 69 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.95106555 |
| 70 | lipid particle organization (GO:0034389) | 2.91018589 |
| 71 | barbed-end actin filament capping (GO:0051016) | 2.90989740 |
| 72 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.90921571 |
| 73 | creatine metabolic process (GO:0006600) | 2.90276578 |
| 74 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.88102059 |
| 75 | ovulation from ovarian follicle (GO:0001542) | 2.87285129 |
| 76 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.86811164 |
| 77 | glomerular filtration (GO:0003094) | 2.86433163 |
| 78 | fibril organization (GO:0097435) | 2.86368813 |
| 79 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.85733908 |
| 80 | regulation of coenzyme metabolic process (GO:0051196) | 2.84930982 |
| 81 | regulation of cofactor metabolic process (GO:0051193) | 2.84930982 |
| 82 | cGMP-mediated signaling (GO:0019934) | 2.84805521 |
| 83 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.83290075 |
| 84 | stress fiber assembly (GO:0043149) | 2.83200362 |
| 85 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.82048206 |
| 86 | succinate metabolic process (GO:0006105) | 2.81404281 |
| 87 | regulation of p38MAPK cascade (GO:1900744) | 2.79870735 |
| 88 | renal filtration (GO:0097205) | 2.79398180 |
| 89 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.78844685 |
| 90 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.77957094 |
| 91 | response to mercury ion (GO:0046689) | 2.76932129 |
| 92 | cardiac muscle hypertrophy (GO:0003300) | 2.74008999 |
| 93 | endocrine hormone secretion (GO:0060986) | 2.72049848 |
| 94 | regulation of cholesterol storage (GO:0010885) | 2.69556308 |
| 95 | cell communication involved in cardiac conduction (GO:0086065) | 2.68114858 |
| 96 | regulation of the force of heart contraction (GO:0002026) | 2.67536307 |
| 97 | triglyceride catabolic process (GO:0019433) | 2.66916492 |
| 98 | regulation of relaxation of muscle (GO:1901077) | 2.65059678 |
| 99 | muscle tissue morphogenesis (GO:0060415) | 2.65005316 |
| 100 | chemical homeostasis within a tissue (GO:0048875) | 2.64396749 |
| 101 | positive regulation of receptor recycling (GO:0001921) | 2.63597043 |
| 102 | striated muscle hypertrophy (GO:0014897) | 2.62511865 |
| 103 | amino-acid betaine metabolic process (GO:0006577) | 2.62263570 |
| 104 | apoptotic cell clearance (GO:0043277) | 2.59794686 |
| 105 | actin filament-based movement (GO:0030048) | 2.59501128 |
| 106 | adult heart development (GO:0007512) | 2.58806999 |
| 107 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.58777336 |
| 108 | regulation of cardioblast differentiation (GO:0051890) | 2.56711278 |
| 109 | basement membrane organization (GO:0071711) | 2.56039437 |
| 110 | regulation of striated muscle contraction (GO:0006942) | 2.55383543 |
| 111 | keratan sulfate catabolic process (GO:0042340) | 2.52432065 |
| 112 | acylglycerol catabolic process (GO:0046464) | 2.52420561 |
| 113 | neutral lipid catabolic process (GO:0046461) | 2.52420561 |
| 114 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.52310899 |
| 115 | alpha-linolenic acid metabolic process (GO:0036109) | 2.51976008 |
| 116 | striated muscle contraction (GO:0006941) | 2.51833528 |
| 117 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.49419407 |
| 118 | negative regulation of heart growth (GO:0061117) | 2.49419407 |
| 119 | long-chain fatty acid transport (GO:0015909) | 2.49096482 |
| 120 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.48487730 |
| 121 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.48233161 |
| 122 | glomerular basement membrane development (GO:0032836) | 2.48148938 |
| 123 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.46595662 |
| 124 | atrioventricular valve morphogenesis (GO:0003181) | 2.46404558 |
| 125 | adherens junction assembly (GO:0034333) | 2.44834273 |
| 126 | endothelial cell chemotaxis (GO:0035767) | 2.44705048 |
| 127 | cell-substrate adherens junction assembly (GO:0007045) | 2.44137442 |
| 128 | focal adhesion assembly (GO:0048041) | 2.44137442 |
| 129 | cell volume homeostasis (GO:0006884) | 2.43565399 |
| 130 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.42759907 |
| 131 | polyol transport (GO:0015791) | 2.42206774 |
| 132 | cellular response to monoamine stimulus (GO:0071868) | 2.41899871 |
| 133 | cellular response to catecholamine stimulus (GO:0071870) | 2.41899871 |
| 134 | negative regulation of protein localization to cell surface (GO:2000009) | 2.40090173 |
| 135 | muscle hypertrophy (GO:0014896) | 2.39368941 |
| 136 | endothelium development (GO:0003158) | 2.36979283 |
| 137 | metanephric nephron epithelium development (GO:0072243) | 2.36642544 |
| 138 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.32796274 |
| 139 | venous blood vessel morphogenesis (GO:0048845) | 2.31629163 |
| 140 | negative regulation of complement activation (GO:0045916) | 2.31379245 |
| 141 | transcytosis (GO:0045056) | 2.30080917 |
| 142 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.29784969 |
| 143 | import into cell (GO:0098657) | 2.26806573 |
| 144 | positive regulation of cholesterol efflux (GO:0010875) | 2.24583291 |
| 145 | metanephric tubule development (GO:0072170) | 2.23135244 |
| 146 | metanephric nephron tubule development (GO:0072234) | 2.23135244 |
| 147 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.22775408 |
| 148 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.22613030 |
| 149 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.20136363 |
| 150 | negative regulation of granulocyte differentiation (GO:0030853) | 2.19669124 |
| 151 | response to catecholamine (GO:0071869) | 2.19526985 |
| 152 | response to monoamine (GO:0071867) | 2.19526985 |
| 153 | muscle contraction (GO:0006936) | 2.19525647 |
| 154 | * cell-substrate junction assembly (GO:0007044) | 2.19488524 |
| 155 | negative regulation of fatty acid transport (GO:2000192) | 2.19094816 |
| 156 | positive regulation of lipid storage (GO:0010884) | 2.19072222 |
| 157 | activation of protein kinase A activity (GO:0034199) | 2.18531164 |
| 158 | positive regulation of glucose import (GO:0046326) | 2.17637718 |
| 159 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.16201480 |
| 160 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.15896761 |
| 161 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.14759488 |
| 162 | metanephric epithelium development (GO:0072207) | 2.14515526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.30694994 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.66062958 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.60592621 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.17845891 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.13777931 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.86199916 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.81916414 |
| 8 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.70886671 |
| 9 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.63326078 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.57661364 |
| 11 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.45195465 |
| 12 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.45195465 |
| 13 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.26675174 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.25962786 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.05351425 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.03637341 |
| 17 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.99170732 |
| 18 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.95819623 |
| 19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.90799996 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.88028018 |
| 21 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.87192675 |
| 22 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.75919997 |
| 23 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.75719160 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72933580 |
| 25 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.70580586 |
| 26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.65543273 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62963400 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.60181158 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56235851 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53772081 |
| 31 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.44838277 |
| 32 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42298776 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39562474 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.39021741 |
| 35 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37619813 |
| 36 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.37458130 |
| 37 | CJUN_26792858_Chip-Seq_BT549_Human | 1.36890593 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36005097 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.35481703 |
| 40 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.34148910 |
| 41 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.31389607 |
| 42 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30217248 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.29200223 |
| 44 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.25736483 |
| 45 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.25656863 |
| 46 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.25175311 |
| 47 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.24890610 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.24532571 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.23993421 |
| 50 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.23515686 |
| 51 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.23515686 |
| 52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22787855 |
| 53 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22247976 |
| 54 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.21381873 |
| 55 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.20720335 |
| 56 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.19882523 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18903379 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17674184 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13160612 |
| 60 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.11609674 |
| 61 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10317344 |
| 62 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.09752960 |
| 63 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.04267266 |
| 64 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.03022625 |
| 65 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02936728 |
| 66 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.02198238 |
| 67 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02114475 |
| 68 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02025443 |
| 69 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99267852 |
| 70 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98967091 |
| 71 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98686862 |
| 72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98442620 |
| 73 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.97696769 |
| 74 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.97275608 |
| 75 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97172901 |
| 76 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97037535 |
| 77 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96532018 |
| 78 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96192243 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95336691 |
| 80 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95122837 |
| 81 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93694201 |
| 82 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93006171 |
| 83 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92728853 |
| 84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92204802 |
| 85 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92011454 |
| 86 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.91734461 |
| 87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.91631853 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91192165 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91192165 |
| 90 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91112975 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90991681 |
| 92 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90630558 |
| 93 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.90484280 |
| 94 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.89990329 |
| 95 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89698489 |
| 96 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89385398 |
| 97 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.88866666 |
| 98 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88739436 |
| 99 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88673566 |
| 100 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.88661046 |
| 101 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.88347878 |
| 102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88097455 |
| 103 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.88089474 |
| 104 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87550374 |
| 105 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87178528 |
| 106 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.87156182 |
| 107 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86927291 |
| 108 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86615945 |
| 109 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86295636 |
| 110 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.85862931 |
| 111 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85027593 |
| 112 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84917264 |
| 113 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.84334140 |
| 114 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84286077 |
| 115 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83903226 |
| 116 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83771835 |
| 117 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83458570 |
| 118 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.83142258 |
| 119 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83094704 |
| 120 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82871819 |
| 121 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.82409774 |
| 122 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81867953 |
| 123 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.81800357 |
| 124 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81494960 |
| 125 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81050545 |
| 126 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.80879652 |
| 127 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.80679572 |
| 128 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.80195036 |
| 129 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80089461 |
| 130 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.79805119 |
| 131 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.78947280 |
| 132 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.78419590 |
| 133 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77879914 |
| 134 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.77751573 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.97551511 |
| 2 | MP0004084_abnormal_cardiac_muscle | 3.83518730 |
| 3 | MP0005670_abnormal_white_adipose | 3.66044785 |
| 4 | MP0000751_myopathy | 3.60416529 |
| 5 | MP0003646_muscle_fatigue | 3.26910009 |
| 6 | MP0004130_abnormal_muscle_cell | 3.08370662 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 3.01220055 |
| 8 | MP0004036_abnormal_muscle_relaxation | 2.89849528 |
| 9 | MP0004215_abnormal_myocardial_fiber | 2.88132353 |
| 10 | MP0005666_abnormal_adipose_tissue | 2.75652929 |
| 11 | MP0005330_cardiomyopathy | 2.71364120 |
| 12 | MP0000749_muscle_degeneration | 2.44213281 |
| 13 | MP0008775_abnormal_heart_ventricle | 2.29609011 |
| 14 | MP0004087_abnormal_muscle_fiber | 2.22256630 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.20977975 |
| 16 | MP0002972_abnormal_cardiac_muscle | 2.17627208 |
| 17 | MP0001958_emphysema | 2.16750716 |
| 18 | MP0010368_abnormal_lymphatic_system | 2.15241790 |
| 19 | MP0006138_congestive_heart_failure | 2.15028762 |
| 20 | MP0005275_abnormal_skin_tensile | 2.12420118 |
| 21 | MP0000750_abnormal_muscle_regeneration | 2.08627171 |
| 22 | MP0001544_abnormal_cardiovascular_syste | 2.04932531 |
| 23 | MP0005385_cardiovascular_system_phenoty | 2.04932531 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 2.04353952 |
| 25 | MP0005375_adipose_tissue_phenotype | 2.01881469 |
| 26 | MP0005620_abnormal_muscle_contractility | 2.01036030 |
| 27 | MP0004272_abnormal_basement_membrane | 1.96463465 |
| 28 | MP0010630_abnormal_cardiac_muscle | 1.87309708 |
| 29 | MP0003828_pulmonary_edema | 1.85155603 |
| 30 | MP0005360_urolithiasis | 1.83792641 |
| 31 | MP0003279_aneurysm | 1.70874784 |
| 32 | MP0004484_altered_response_of | 1.63069975 |
| 33 | MP0003091_abnormal_cell_migration | 1.60409387 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.54089081 |
| 35 | MP0003137_abnormal_impulse_conducting | 1.51829031 |
| 36 | MP0001879_abnormal_lymphatic_vessel | 1.51537610 |
| 37 | MP0002269_muscular_atrophy | 1.51210189 |
| 38 | MP0002106_abnormal_muscle_physiology | 1.51169038 |
| 39 | MP0000013_abnormal_adipose_tissue | 1.50328307 |
| 40 | MP0002139_abnormal_hepatobiliary_system | 1.40248843 |
| 41 | MP0000759_abnormal_skeletal_muscle | 1.37823903 |
| 42 | MP0005332_abnormal_amino_acid | 1.37666130 |
| 43 | MP0002971_abnormal_brown_adipose | 1.37158314 |
| 44 | MP0000747_muscle_weakness | 1.36494080 |
| 45 | MP0000343_altered_response_to | 1.34825136 |
| 46 | MP0000003_abnormal_adipose_tissue | 1.33608063 |
| 47 | MP0008004_abnormal_stomach_pH | 1.30757886 |
| 48 | MP0005369_muscle_phenotype | 1.30545108 |
| 49 | MP0005023_abnormal_wound_healing | 1.28976766 |
| 50 | MP0004085_abnormal_heartbeat | 1.27509447 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.25831150 |
| 52 | MP0004043_abnormal_pH_regulation | 1.25438032 |
| 53 | MP0001756_abnormal_urination | 1.24017466 |
| 54 | MP0005164_abnormal_response_to | 1.22719101 |
| 55 | MP0010329_abnormal_lipoprotein_level | 1.22403815 |
| 56 | MP0002933_joint_inflammation | 1.21341367 |
| 57 | * MP0003566_abnormal_cell_adhesion | 1.20411641 |
| 58 | MP0005365_abnormal_bile_salt | 1.20253752 |
| 59 | MP0003950_abnormal_plasma_membrane | 1.17422618 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.17191090 |
| 61 | MP0001542_abnormal_bone_strength | 1.13982688 |
| 62 | MP0000230_abnormal_systemic_arterial | 1.12935580 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 1.10737925 |
| 64 | MP0008961_abnormal_basal_metabolism | 1.10482809 |
| 65 | MP0002118_abnormal_lipid_homeostasis | 1.10336647 |
| 66 | MP0003252_abnormal_bile_duct | 1.09712098 |
| 67 | MP0003221_abnormal_cardiomyocyte_apopto | 1.09595934 |
| 68 | MP0003045_fibrosis | 1.09423791 |
| 69 | MP0003690_abnormal_glial_cell | 1.07855376 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.06204528 |
| 71 | MP0005409_darkened_coat_color | 1.05610727 |
| 72 | MP0002108_abnormal_muscle_morphology | 1.05446495 |
| 73 | MP0004233_abnormal_muscle_weight | 1.05371420 |
| 74 | MP0009115_abnormal_fat_cell | 1.04450592 |
| 75 | MP0005388_respiratory_system_phenotype | 1.02395663 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 1.02125465 |
| 77 | MP0002332_abnormal_exercise_endurance | 1.00521312 |
| 78 | MP0005165_increased_susceptibility_to | 1.00201517 |
| 79 | MP0002998_abnormal_bone_remodeling | 0.99295472 |
| 80 | MP0004145_abnormal_muscle_electrophysio | 0.98705969 |
| 81 | MP0005503_abnormal_tendon_morphology | 0.98238959 |
| 82 | MP0000767_abnormal_smooth_muscle | 0.97614061 |
| 83 | MP0002295_abnormal_pulmonary_circulatio | 0.96639167 |
| 84 | MP0008875_abnormal_xenobiotic_pharmacok | 0.95897360 |
| 85 | MP0005623_abnormal_meninges_morphology | 0.95304315 |
| 86 | MP0001765_abnormal_ion_homeostasis | 0.93833379 |
| 87 | MP0005334_abnormal_fat_pad | 0.92714808 |
| 88 | MP0002896_abnormal_bone_mineralization | 0.90638630 |
| 89 | MP0005508_abnormal_skeleton_morphology | 0.88805812 |
| 90 | MP0000266_abnormal_heart_morphology | 0.88778661 |
| 91 | MP0004510_myositis | 0.88163928 |
| 92 | MP0002060_abnormal_skin_morphology | 0.86987596 |
| 93 | MP0002168_other_aberrant_phenotype | 0.86161740 |
| 94 | * MP0002128_abnormal_blood_circulation | 0.85440329 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 0.85283101 |
| 96 | MP0000733_abnormal_muscle_development | 0.84936410 |
| 97 | MP0003879_abnormal_hair_cell | 0.83234645 |
| 98 | MP0002127_abnormal_cardiovascular_syste | 0.83161801 |
| 99 | MP0004883_abnormal_blood_vessel | 0.82634275 |
| 100 | MP0005085_abnormal_gallbladder_physiolo | 0.82242408 |
| 101 | MP0003300_gastrointestinal_ulcer | 0.81945772 |
| 102 | MP0001614_abnormal_blood_vessel | 0.78841599 |
| 103 | MP0005535_abnormal_body_temperature | 0.78205744 |
| 104 | MP0004782_abnormal_surfactant_physiolog | 0.77968182 |
| 105 | MP0003303_peritoneal_inflammation | 0.77947229 |
| 106 | MP0003868_abnormal_feces_composition | 0.76706484 |
| 107 | MP0003959_abnormal_lean_body | 0.76701430 |
| 108 | MP0001661_extended_life_span | 0.75074768 |
| 109 | MP0005257_abnormal_intraocular_pressure | 0.74893594 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74058423 |
| 111 | MP0009384_cardiac_valve_regurgitation | 0.73887720 |
| 112 | MP0005595_abnormal_vascular_smooth | 0.73158301 |
| 113 | * MP0002136_abnormal_kidney_physiology | 0.72398921 |
| 114 | MP0009780_abnormal_chondrocyte_physiolo | 0.71217085 |
| 115 | MP0000609_abnormal_liver_physiology | 0.71066554 |
| 116 | MP0005058_abnormal_lysosome_morphology | 0.70949543 |
| 117 | MP0002970_abnormal_white_adipose | 0.69171053 |
| 118 | MP0009840_abnormal_foam_cell | 0.68440216 |
| 119 | MP0003195_calcinosis | 0.67716060 |
| 120 | MP0003075_altered_response_to | 0.66101310 |
| 121 | MP0000249_abnormal_blood_vessel | 0.66072310 |
| 122 | MP0003567_abnormal_fetal_cardiomyocyte | 0.65065342 |
| 123 | MP0004019_abnormal_vitamin_homeostasis | 0.64814236 |
| 124 | MP0003724_increased_susceptibility_to | 0.64440937 |
| 125 | MP0002078_abnormal_glucose_homeostasis | 0.64135889 |
| 126 | MP0002133_abnormal_respiratory_system | 0.63880127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 5.45856684 |
| 2 | Muscle fiber splitting (HP:0003555) | 5.13928079 |
| 3 | Ventricular tachycardia (HP:0004756) | 4.60537005 |
| 4 | Increased connective tissue (HP:0009025) | 4.39246907 |
| 5 | Right ventricular cardiomyopathy (HP:0011663) | 4.37901647 |
| 6 | Hyporeflexia of lower limbs (HP:0002600) | 4.30790278 |
| 7 | Myoglobinuria (HP:0002913) | 3.98217700 |
| 8 | Lipoatrophy (HP:0100578) | 3.94917063 |
| 9 | Atrial fibrillation (HP:0005110) | 3.80656573 |
| 10 | Exercise-induced myalgia (HP:0003738) | 3.76706732 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 3.72695404 |
| 12 | Primary atrial arrhythmia (HP:0001692) | 3.49894901 |
| 13 | Difficulty running (HP:0009046) | 3.48857199 |
| 14 | Exercise-induced muscle cramps (HP:0003710) | 3.48092382 |
| 15 | Abnormality of the calf musculature (HP:0001430) | 3.46650689 |
| 16 | Hyperglycinuria (HP:0003108) | 3.38707282 |
| 17 | Supraventricular arrhythmia (HP:0005115) | 3.34809015 |
| 18 | Supraventricular tachycardia (HP:0004755) | 3.31905372 |
| 19 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.30475904 |
| 20 | Broad metatarsal (HP:0001783) | 3.29546109 |
| 21 | Ketoacidosis (HP:0001993) | 3.24555403 |
| 22 | Asymmetric septal hypertrophy (HP:0001670) | 3.22041568 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.19706592 |
| 24 | Complement deficiency (HP:0004431) | 3.11452296 |
| 25 | Dilated cardiomyopathy (HP:0001644) | 3.09133420 |
| 26 | Palpitations (HP:0001962) | 2.99905117 |
| 27 | Rhabdomyolysis (HP:0003201) | 2.93934377 |
| 28 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.92691789 |
| 29 | Subaortic stenosis (HP:0001682) | 2.92691789 |
| 30 | Syncope (HP:0001279) | 2.92682488 |
| 31 | Vascular tortuosity (HP:0004948) | 2.91360694 |
| 32 | Type 1 muscle fiber predominance (HP:0003803) | 2.90513925 |
| 33 | Bundle branch block (HP:0011710) | 2.87514757 |
| 34 | Ketosis (HP:0001946) | 2.84604580 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 2.84369125 |
| 36 | EMG: myopathic abnormalities (HP:0003458) | 2.77376482 |
| 37 | Hypoglycemic coma (HP:0001325) | 2.74941469 |
| 38 | Atrioventricular block (HP:0001678) | 2.73504053 |
| 39 | Abnormality of complement system (HP:0005339) | 2.72512554 |
| 40 | Prolonged QT interval (HP:0001657) | 2.72325649 |
| 41 | Cerebral aneurysm (HP:0004944) | 2.71942603 |
| 42 | Abnormality of glycine metabolism (HP:0010895) | 2.71328850 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.71328850 |
| 44 | Gout (HP:0001997) | 2.66425786 |
| 45 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.60656486 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.60551742 |
| 47 | Wormian bones (HP:0002645) | 2.59759910 |
| 48 | Ventricular arrhythmia (HP:0004308) | 2.58619320 |
| 49 | Facial diplegia (HP:0001349) | 2.58396652 |
| 50 | Arterial tortuosity (HP:0005116) | 2.57718837 |
| 51 | Myotonia (HP:0002486) | 2.56172724 |
| 52 | Lymphangioma (HP:0100764) | 2.54754948 |
| 53 | Neck muscle weakness (HP:0000467) | 2.54082390 |
| 54 | Shallow orbits (HP:0000586) | 2.53979476 |
| 55 | Muscle fiber inclusion bodies (HP:0100299) | 2.53801881 |
| 56 | Difficulty climbing stairs (HP:0003551) | 2.52602219 |
| 57 | Dicarboxylic aciduria (HP:0003215) | 2.52254492 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.52254492 |
| 59 | Hyperactive renin-angiotensin system (HP:0000841) | 2.51009872 |
| 60 | Aortic aneurysm (HP:0004942) | 2.50241942 |
| 61 | Round ear (HP:0100830) | 2.50027647 |
| 62 | Heart block (HP:0012722) | 2.49838263 |
| 63 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.49745304 |
| 64 | Interstitial pulmonary disease (HP:0006530) | 2.46908427 |
| 65 | Dilatation of the ascending aorta (HP:0005111) | 2.45385043 |
| 66 | Abnormal atrioventricular conduction (HP:0005150) | 2.44244464 |
| 67 | Polycythemia (HP:0001901) | 2.43927765 |
| 68 | Nemaline bodies (HP:0003798) | 2.43659308 |
| 69 | Mitral valve prolapse (HP:0001634) | 2.43158899 |
| 70 | Obstructive sleep apnea (HP:0002870) | 2.43082536 |
| 71 | Soft skin (HP:0000977) | 2.37015449 |
| 72 | Osteolytic defects of the hand bones (HP:0009699) | 2.36120868 |
| 73 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.36120868 |
| 74 | Distal lower limb amyotrophy (HP:0008944) | 2.35036854 |
| 75 | Aortic regurgitation (HP:0001659) | 2.33995115 |
| 76 | Overgrowth (HP:0001548) | 2.32407099 |
| 77 | Hyperammonemia (HP:0001987) | 2.30364670 |
| 78 | Ankle contracture (HP:0006466) | 2.29036079 |
| 79 | Protrusio acetabuli (HP:0003179) | 2.28705053 |
| 80 | Hypokalemic alkalosis (HP:0001949) | 2.27985728 |
| 81 | Aortic dissection (HP:0002647) | 2.26532403 |
| 82 | Premature rupture of membranes (HP:0001788) | 2.24414029 |
| 83 | Generalized aminoaciduria (HP:0002909) | 2.22907514 |
| 84 | Acanthosis nigricans (HP:0000956) | 2.21478961 |
| 85 | Spinal rigidity (HP:0003306) | 2.17934857 |
| 86 | Distal lower limb muscle weakness (HP:0009053) | 2.16805880 |
| 87 | Hyperuricemia (HP:0002149) | 2.16538319 |
| 88 | Increased purine levels (HP:0004368) | 2.16538319 |
| 89 | Aneurysm (HP:0002617) | 2.16132983 |
| 90 | Striae distensae (HP:0001065) | 2.14577420 |
| 91 | Proximal tubulopathy (HP:0000114) | 2.14200098 |
| 92 | Cervical subluxation (HP:0003308) | 2.13783157 |
| 93 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.12572830 |
| 94 | Myocardial infarction (HP:0001658) | 2.10166405 |
| 95 | Oligomenorrhea (HP:0000876) | 2.08486656 |
| 96 | Generalized muscle weakness (HP:0003324) | 2.08471193 |
| 97 | Abnormality of proline metabolism (HP:0010907) | 2.08208300 |
| 98 | Hydroxyprolinuria (HP:0003080) | 2.08208300 |
| 99 | Ventricular fibrillation (HP:0001663) | 2.06686576 |
| 100 | Skin nodule (HP:0200036) | 2.06493678 |
| 101 | Scapular winging (HP:0003691) | 2.06239012 |
| 102 | Abnormality of chloride homeostasis (HP:0011422) | 2.05870494 |
| 103 | Hypoplasia of the iris (HP:0007676) | 2.01847232 |
| 104 | Bladder diverticulum (HP:0000015) | 2.01195097 |
| 105 | Testicular atrophy (HP:0000029) | 2.00695358 |
| 106 | Muscle stiffness (HP:0003552) | 2.00225650 |
| 107 | Abnormality of purine metabolism (HP:0004352) | 1.98102773 |
| 108 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.98094649 |
| 109 | Mitral stenosis (HP:0001718) | 1.97369591 |
| 110 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.97340476 |
| 111 | Glomerulonephritis (HP:0000099) | 1.96281167 |
| 112 | Wrist flexion contracture (HP:0001239) | 1.95204526 |
| 113 | Increased circulating renin level (HP:0000848) | 1.94696900 |
| 114 | Persistence of primary teeth (HP:0006335) | 1.92686220 |
| 115 | Bone cyst (HP:0012062) | 1.90667331 |
| 116 | Visceral angiomatosis (HP:0100761) | 1.90609440 |
| 117 | Long toe (HP:0010511) | 1.89724133 |
| 118 | Neoplasm of the heart (HP:0100544) | 1.89525761 |
| 119 | Hip contracture (HP:0003273) | 1.88601741 |
| 120 | Conjunctival hamartoma (HP:0100780) | 1.88419939 |
| 121 | Foot dorsiflexor weakness (HP:0009027) | 1.88329804 |
| 122 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.88213042 |
| 123 | Slender build (HP:0001533) | 1.88161086 |
| 124 | Neonatal death (HP:0003811) | 1.87279445 |
| 125 | Ulnar deviation of the wrist (HP:0003049) | 1.86084119 |
| 126 | Hematochezia (HP:0002573) | 1.85910564 |
| 127 | Vertebral compression fractures (HP:0002953) | 1.85576015 |
| 128 | Bradycardia (HP:0001662) | 1.84652020 |
| 129 | Hemorrhage of the eye (HP:0011885) | 1.84434786 |
| 130 | Abnormality of the foot musculature (HP:0001436) | 1.84242438 |
| 131 | Mitral regurgitation (HP:0001653) | 1.83924075 |
| 132 | Esophageal varix (HP:0002040) | 1.83798331 |
| 133 | Pulmonary artery stenosis (HP:0004415) | 1.83556300 |
| 134 | Increased muscle lipid content (HP:0009058) | 1.83408500 |
| 135 | Fragile skin (HP:0001030) | 1.82304615 |
| 136 | Metabolic alkalosis (HP:0200114) | 1.81768267 |
| 137 | Joint laxity (HP:0001388) | 1.81467780 |
| 138 | Hypoalphalipoproteinemia (HP:0003233) | 1.79578492 |
| 139 | Nausea (HP:0002018) | 1.78438899 |
| 140 | Stroke (HP:0001297) | 1.78156804 |
| 141 | Abnormal urine output (HP:0012590) | 1.77540992 |
| 142 | Hypertriglyceridemia (HP:0002155) | 1.77129240 |
| 143 | Peritonitis (HP:0002586) | 1.76877978 |
| 144 | Bulbar palsy (HP:0001283) | 1.76406835 |
| 145 | Spontaneous hematomas (HP:0007420) | 1.76282121 |
| 146 | Blue sclerae (HP:0000592) | 1.76279010 |
| 147 | Limited hip movement (HP:0008800) | 1.75952490 |
| 148 | Hyperaldosteronism (HP:0000859) | 1.74854739 |
| 149 | Hemangiomatosis (HP:0007461) | 1.73990131 |
| 150 | Limb-girdle muscle atrophy (HP:0003797) | 1.73112011 |
| 151 | Abnormal EKG (HP:0003115) | 1.72489085 |
| 152 | Hyperkalemia (HP:0002153) | 1.71509834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.32480242 |
| 2 | TRIB3 | 3.94154556 |
| 3 | MYLK | 3.30621144 |
| 4 | TIE1 | 3.22234794 |
| 5 | LMTK2 | 3.01414891 |
| 6 | PDK4 | 2.87558030 |
| 7 | PDK3 | 2.87558030 |
| 8 | BCKDK | 2.85970559 |
| 9 | WNK4 | 2.58475693 |
| 10 | PKN2 | 2.22668674 |
| 11 | DMPK | 2.22266541 |
| 12 | PHKG2 | 2.19714038 |
| 13 | PHKG1 | 2.19714038 |
| 14 | TGFBR2 | 2.17318881 |
| 15 | RIPK1 | 2.12279516 |
| 16 | CAMK1D | 2.10286349 |
| 17 | AKT3 | 2.07527530 |
| 18 | SIK1 | 2.05783920 |
| 19 | PDK2 | 2.03798724 |
| 20 | OBSCN | 1.97278043 |
| 21 | ERN1 | 1.87282706 |
| 22 | CAMK1G | 1.67909538 |
| 23 | MAP3K6 | 1.62321358 |
| 24 | PDGFRA | 1.61808885 |
| 25 | PIK3CA | 1.53399471 |
| 26 | PRPF4B | 1.37541597 |
| 27 | LATS1 | 1.31501823 |
| 28 | EPHB1 | 1.31061160 |
| 29 | EPHB2 | 1.16903972 |
| 30 | FGFR4 | 1.16288169 |
| 31 | STK39 | 1.15139170 |
| 32 | PRKAA2 | 1.11732016 |
| 33 | INSRR | 1.10379451 |
| 34 | MAPK7 | 1.09594591 |
| 35 | PRKD1 | 1.07999883 |
| 36 | PINK1 | 1.07149961 |
| 37 | SGK2 | 1.06498095 |
| 38 | PTK2B | 1.02660607 |
| 39 | KDR | 1.01855146 |
| 40 | MAP2K3 | 1.01338437 |
| 41 | STK38L | 1.00903840 |
| 42 | MAP3K7 | 1.00248505 |
| 43 | WNK3 | 1.00235872 |
| 44 | OXSR1 | 0.98652980 |
| 45 | RPS6KA2 | 0.97963834 |
| 46 | NEK1 | 0.96784196 |
| 47 | MAPKAPK3 | 0.96736218 |
| 48 | PTK6 | 0.95924010 |
| 49 | MAPK4 | 0.91607155 |
| 50 | PAK3 | 0.89825333 |
| 51 | FER | 0.89791808 |
| 52 | WNK1 | 0.89341924 |
| 53 | ILK | 0.88850607 |
| 54 | MAP3K3 | 0.88208426 |
| 55 | NLK | 0.87364462 |
| 56 | LRRK2 | 0.84978758 |
| 57 | SGK494 | 0.84866527 |
| 58 | SGK223 | 0.84866527 |
| 59 | PRKAA1 | 0.81465246 |
| 60 | MST1R | 0.81435323 |
| 61 | ROCK1 | 0.81075071 |
| 62 | DDR2 | 0.80933486 |
| 63 | STK38 | 0.80896806 |
| 64 | BLK | 0.80263732 |
| 65 | KIT | 0.79378097 |
| 66 | HIPK2 | 0.78973001 |
| 67 | MAPK12 | 0.75064192 |
| 68 | NEK9 | 0.73431183 |
| 69 | PDPK1 | 0.72991771 |
| 70 | FGFR2 | 0.71129180 |
| 71 | TRPM7 | 0.69318738 |
| 72 | ZAP70 | 0.68831322 |
| 73 | TESK1 | 0.68062502 |
| 74 | LATS2 | 0.67963940 |
| 75 | PAK2 | 0.66769088 |
| 76 | FGFR3 | 0.66715440 |
| 77 | ICK | 0.65700631 |
| 78 | CDK12 | 0.65033769 |
| 79 | MAP3K13 | 0.64781498 |
| 80 | STK24 | 0.64404989 |
| 81 | PRKD3 | 0.64127163 |
| 82 | MTOR | 0.62799372 |
| 83 | PDGFRB | 0.61197623 |
| 84 | PRKCH | 0.59382045 |
| 85 | JAK1 | 0.59007504 |
| 86 | CDC42BPA | 0.58925401 |
| 87 | EPHA3 | 0.56734028 |
| 88 | MET | 0.55253494 |
| 89 | SGK3 | 0.54993040 |
| 90 | MAP3K1 | 0.54274403 |
| 91 | FLT3 | 0.53804191 |
| 92 | CSK | 0.53202529 |
| 93 | PIK3CG | 0.51890846 |
| 94 | RET | 0.51191443 |
| 95 | PTK2 | 0.50442388 |
| 96 | TYK2 | 0.49039902 |
| 97 | ABL2 | 0.48865095 |
| 98 | PAK4 | 0.48581703 |
| 99 | DAPK3 | 0.48196505 |
| 100 | GSK3A | 0.46156075 |
| 101 | MOS | 0.43956897 |
| 102 | TAOK1 | 0.43881352 |
| 103 | PRKG2 | 0.42354609 |
| 104 | PDK1 | 0.41834034 |
| 105 | GRK5 | 0.41795233 |
| 106 | MUSK | 0.40975126 |
| 107 | CAMK4 | 0.40718462 |
| 108 | TGFBR1 | 0.40571993 |
| 109 | TAOK2 | 0.40462414 |
| 110 | CAMK2D | 0.39200262 |
| 111 | MAP2K1 | 0.38594846 |
| 112 | PRKACG | 0.37979013 |
| 113 | NTRK1 | 0.37892110 |
| 114 | MAPK3 | 0.36864034 |
| 115 | CAMK2G | 0.36228461 |
| 116 | PRKG1 | 0.35976212 |
| 117 | CAMK1 | 0.35970328 |
| 118 | PRKD2 | 0.35818690 |
| 119 | JAK2 | 0.35773849 |
| 120 | MAPK15 | 0.35760103 |
| 121 | KSR2 | 0.35576060 |
| 122 | BMX | 0.35124989 |
| 123 | EEF2K | 0.34973952 |
| 124 | ROCK2 | 0.33630877 |
| 125 | RPS6KL1 | 0.32381032 |
| 126 | RPS6KC1 | 0.32381032 |
| 127 | GRK7 | 0.31675119 |
| 128 | MAP3K5 | 0.30915740 |
| 129 | MARK2 | 0.28859563 |
| 130 | MAPK11 | 0.27908462 |
| 131 | RPS6KA6 | 0.27859667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.27919512 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.74943033 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.55046104 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.28337443 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.04330472 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.79569247 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.57387634 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.20923542 |
| 9 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.12256519 |
| 10 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.11708185 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.09573104 |
| 12 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.09150891 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.02165629 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86086150 |
| 15 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.77721057 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.71410785 |
| 17 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.60377798 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.59577211 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.58395477 |
| 20 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.58193588 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.48275272 |
| 22 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.47560085 |
| 23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.41717899 |
| 24 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.38100647 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.34733654 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26638778 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24946531 |
| 28 | Insulin resistance_Homo sapiens_hsa04931 | 1.24358874 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.21872789 |
| 30 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.21097809 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.19773379 |
| 32 | Circadian rhythm_Homo sapiens_hsa04710 | 1.19171842 |
| 33 | Lysine degradation_Homo sapiens_hsa00310 | 1.18045620 |
| 34 | Focal adhesion_Homo sapiens_hsa04510 | 1.16906987 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.10582658 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10488202 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07319580 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.04838251 |
| 39 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.04477891 |
| 40 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.01642177 |
| 41 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.01583780 |
| 42 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01517454 |
| 43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.99947299 |
| 44 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99094739 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 0.97765635 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.97255991 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94302516 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.93979710 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92478075 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 0.90136783 |
| 51 | Prion diseases_Homo sapiens_hsa05020 | 0.89985222 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89211436 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87331069 |
| 54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.85568582 |
| 55 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.85428973 |
| 56 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.83945707 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83147264 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.81831468 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.81663026 |
| 60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76900280 |
| 61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.75763791 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.74931835 |
| 63 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.74133230 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73612766 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.71637026 |
| 66 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67776434 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.67697990 |
| 68 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66343715 |
| 69 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65433656 |
| 70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65278737 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64998020 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64649652 |
| 73 | Gap junction_Homo sapiens_hsa04540 | 0.63797177 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.62887164 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62830921 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62801101 |
| 77 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61906562 |
| 78 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61289990 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59094808 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58781686 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58429910 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57699433 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57608086 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.56608566 |
| 85 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55175600 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54324429 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53703157 |
| 88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53626422 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53612202 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53066710 |
| 91 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.53012958 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.52299813 |
| 93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51291460 |
| 94 | Salivary secretion_Homo sapiens_hsa04970 | 0.51087015 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50860684 |
| 96 | Long-term potentiation_Homo sapiens_hsa04720 | 0.50796886 |
| 97 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.50321572 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.49868237 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49556993 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49161473 |
| 101 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48434637 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47713746 |
| 103 | Tight junction_Homo sapiens_hsa04530 | 0.47570143 |
| 104 | Prostate cancer_Homo sapiens_hsa05215 | 0.47336581 |
| 105 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.46475440 |
| 106 | Insulin secretion_Homo sapiens_hsa04911 | 0.46041130 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45960613 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.45929663 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45717713 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45472463 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45342559 |
| 112 | Melanogenesis_Homo sapiens_hsa04916 | 0.44808560 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44773709 |
| 114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44718373 |
| 115 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.44649891 |
| 116 | Circadian entrainment_Homo sapiens_hsa04713 | 0.43578938 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | 0.43511026 |
| 118 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42827773 |
| 119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41318312 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38054127 |
| 121 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.37906630 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.36920865 |
| 123 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.34714040 |
| 124 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.34577990 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32713192 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31356854 |
| 127 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30690068 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30541405 |
| 129 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.30520604 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.30184215 |
| 131 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30176888 |
| 132 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29537969 |
| 133 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29197671 |
| 134 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.25806235 |
| 135 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.25642770 |
| 136 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.25287951 |
| 137 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24986468 |
| 138 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.24761086 |
| 139 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24502174 |
| 140 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.24500207 |
| 141 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.23493695 |
| 142 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.22834445 |
| 143 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.19366501 |
| 144 | Lysosome_Homo sapiens_hsa04142 | 0.18927715 |

